12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)
Clinical trial NCT01362348 · TERMINATED
Trial details
- NCT number
- NCT01362348
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-07
- Primary completion
- 2012-04-16
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.